scispace - formally typeset
J

J. Michael Kilby

Researcher at Medical University of South Carolina

Publications -  55
Citations -  9203

J. Michael Kilby is an academic researcher from Medical University of South Carolina. The author has contributed to research in topics: Viral load & Virus. The author has an hindex of 27, co-authored 55 publications receiving 8772 citations. Previous affiliations of J. Michael Kilby include Institute for Advanced Study & University of Alabama.

Papers
More filters
Journal ArticleDOI

Antibody neutralization and escape by HIV-1

TL;DR: The detection of autologous Nab as early as 52 days after detection of HIV-specific antibodies is reported, indicating a new mechanism contributing to HIV-1 persistence in the face of an evolving antibody repertoire.
Journal ArticleDOI

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

TL;DR: A mathematical model of random viral evolution and phylogenetic tree construction is developed and used to analyze 3,449 complete env sequences derived by single genome amplification from 102 subjects with acute HIV-1 (clade B) infection, suggesting a finite window of potential vulnerability of HIV- 1 to vaccine-elicited immune responses, although phenotypic properties of transmitted Envs pose a formidable defense.
Journal ArticleDOI

Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy

TL;DR: These findings provide the first evidence for the rapid emergence of clinical resistance to a novel class of HIV-1 entry inhibitors and may be relevant to future treatment strategies involving these agents.
Journal ArticleDOI

Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues

TL;DR: In this paper, the authors analyzed blood and lymph node tissues obtained concurrently from HIV-infected patients before and after initiation of HAART and found that activated T cells were significantly more frequent in lymph node tissue compared with blood at both time points.
Journal ArticleDOI

Novel therapies based on mechanisms of HIV-1 cell entry

TL;DR: The way in which HIV-1 enters cells and potential means of denying the virus admission to cells are reviewed.